These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23107315)

  • 1. Comparison of a frozen human foreskin fibroblast cell assay to an enzyme immunoassay and toxigenic culture for the detection of toxigenic Clostridium difficile.
    Strachan AJ; Evans NE; Williams OM; Spencer RC; Greenwood R; Probert CJ
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):42-5. PubMed ID: 23107315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
    Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
    J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of
    Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM
    Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the two-step and the three-step algorithms for the detection of toxigenic Clostridium difficile.
    Qutub MO; AlBaz N; Hawken P; Anoos A
    Indian J Med Microbiol; 2011; 29(3):293-6. PubMed ID: 21860113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.
    René P; Frenette CP; Schiller I; Dendukuri N; Brassard P; Fenn S; Loo VG
    Diagn Microbiol Infect Dis; 2012 May; 73(1):94-6. PubMed ID: 22424900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.
    Luk S; To WK; Ng TK; Hui WT; Lee WK; Lau F; Ching AM
    J Clin Microbiol; 2014 Feb; 52(2):671-3. PubMed ID: 24478510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
    Stamper PD; Alcabasa R; Aird D; Babiker W; Wehrlin J; Ikpeama I; Carroll KC
    J Clin Microbiol; 2009 Feb; 47(2):373-8. PubMed ID: 19073875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.
    Larson AM; Fung AM; Fang FC
    J Clin Microbiol; 2010 Jan; 48(1):124-30. PubMed ID: 19923482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.
    Dubberke ER; Reske KA; Hink T; Kwon JH; Cass C; Bongu J; Burnham CD; Henderson JP
    Infect Control Hosp Epidemiol; 2018 Nov; 39(11):1330-1333. PubMed ID: 30226126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens.
    Buchan BW; Mackey TL; Daly JA; Alger G; Denys GA; Peterson LR; Kehl SC; Ledeboer NA
    J Clin Microbiol; 2012 Dec; 50(12):3932-6. PubMed ID: 23015667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.
    Bruins MJ; Verbeek E; Wallinga JA; Bruijnesteijn van Coppenraet LE; Kuijper EJ; Bloembergen P
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3035-9. PubMed ID: 22706512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea.
    Barbut F; Kajzer C; Planas N; Petit JC
    J Clin Microbiol; 1993 Apr; 31(4):963-7. PubMed ID: 8463404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.
    Hirvonen JJ; Mentula S; Kaukoranta SS
    J Clin Microbiol; 2013 Sep; 51(9):2908-12. PubMed ID: 23804386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.